-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Processa Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q2 2012 to Q1 2024.
- Processa Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $139.000.
- Processa Pharmaceuticals, Inc. annual Depreciation for 2023 was $222.000.
- Processa Pharmaceuticals, Inc. annual Depreciation for 2021 was $484.000, a 94.3% decline from 2020.
- Processa Pharmaceuticals, Inc. annual Depreciation for 2020 was $8.45K, a 0.01% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)